Analyst Recommendations

Wells Fargo analyst issues OVERWEIGHT recommendation for XOM on February 24, 2026 11:37AM ET. The previous analyst recommendation was Overweight.XOM was trading at $150.83 at issue of the...

February 24, 2026   XOM -1.77%

KeyBanc analyst issues OVERWEIGHT recommendation for TPL on February 23, 2026 03:25PM ET. The previous analyst recommendation was Overweight.TPL was trading at $524.94 at issue of the analyst...

February 23, 2026   TPL 8.47%

BMO Capital analyst issues MARKET PERFORM recommendation for FTI on February 23, 2026 01:26PM ET. The previous analyst recommendation was Market Perform.FTI was trading at $63.49 at issue...

February 23, 2026   FTI 0.38%

BMO Capital analyst issues MARKET PERFORM recommendation for OXY on February 23, 2026 01:37PM ET. The previous analyst recommendation was Market Perform.OXY was trading at $51.84 at issue...

February 23, 2026   OXY -0.96%

Susquehanna analyst issues POSITIVE recommendation for RIG on February 23, 2026 12:50PM ET. The previous analyst recommendation was Positive.RIG was trading at $6.52 at issue of the analyst...

February 23, 2026   RIG -0.61%

Barclays analyst issues OVERWEIGHT recommendation for DVN on February 23, 2026 10:43AM ET. The previous analyst recommendation was Overweight.DVN was trading at $44.39 at issue of the analyst...

February 23, 2026   DVN -0.19%

Goldman Sachs analyst issues BUY recommendation for TRGP on February 20, 2026 10:13PM ET. The previous analyst recommendation was Buy.TRGP was trading at $231.35 at issue of the...

February 20, 2026   TRGP -0.68%

Cowen & Co. analyst issues BUY recommendation for FTI on February 20, 2026 06:43PM ET. The previous analyst recommendation was Buy.FTI was trading at $61.945 at issue of...

February 20, 2026   FTI 0.38%

BMO Capital analyst issues OUTPERFORM recommendation for CVE on February 20, 2026 05:27PM ET. The previous analyst recommendation was Outperform.CVE was trading at $22.71 at issue of the...

February 20, 2026   CVE 0.82%

TD Securities analyst issues BUY recommendation for CVE on February 20, 2026 05:41PM ET. The previous analyst recommendation was Buy.CVE was trading at $22.665 at issue of the...

February 20, 2026   CVE 0.82%